[HTML][HTML] World heart federation cholesterol roadmap 2022
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial
infarction, stroke and peripheral arterial disease continue to be major causes of premature …
infarction, stroke and peripheral arterial disease continue to be major causes of premature …
Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
NS Nurmohamed, JM Kraaijenhof, M Mayr… - European Heart …, 2023 - academic.oup.com
Given the limited accuracy of clinically used risk scores such as the Systematic COronary
Risk Evaluation 2 system and the Second Manifestations of ARTerial disease 2 risk scores …
Risk Evaluation 2 system and the Second Manifestations of ARTerial disease 2 risk scores …
[HTML][HTML] Treatment gaps in the implementation of LDL cholesterol control among high-and very high-risk patients in Europe between 2020 and 2021: the multinational …
KK Ray, I Haq, A Bilitou, MC Manu… - The Lancet Regional …, 2023 - thelancet.com
Background European data pre-2019 suggest statin monotherapy is the most common
approach to lipid management for preventing cardiovascular (CV) events, resulting in only …
approach to lipid management for preventing cardiovascular (CV) events, resulting in only …
Cohort profile: the Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease (UCC-SMART) Study–an ongoing prospective cohort study of patients at …
MC Castelijns, MAG Helmink, SHJ Hageman… - BMJ open, 2023 - bmjopen.bmj.com
Purpose The Utrecht Cardiovascular Cohort–Second Manifestations of Arterial Disease
(UCC-SMART) Study is an ongoing prospective single-centre cohort study with the aim to …
(UCC-SMART) Study is an ongoing prospective single-centre cohort study with the aim to …
[HTML][HTML] Lp (a): a new pathway to target?
NS Nurmohamed, JM Kraaijenhof… - Current Atherosclerosis …, 2022 - Springer
Abstract Purpose of Review Over the past decades, genetic and observational evidence has
positioned lipoprotein (a) as novel important and independent risk factor for cardiovascular …
positioned lipoprotein (a) as novel important and independent risk factor for cardiovascular …
Evaluation of large-scale proteomics for prediction of cardiovascular events
H Helgason, T Eiriksdottir, MO Ulfarsson, A Choudhary… - Jama, 2023 - jamanetwork.com
Importance Whether protein risk scores derived from a single plasma sample could be
useful for risk assessment for atherosclerotic cardiovascular disease (ASCVD), in …
useful for risk assessment for atherosclerotic cardiovascular disease (ASCVD), in …
Genetic, sociodemographic, lifestyle, and clinical risk factors of recurrent coronary artery disease events: a population-based cohort study
SMJ Cho, S Koyama, MC Honigberg… - European heart …, 2023 - academic.oup.com
Aims Complications of coronary artery disease (CAD) represent the leading cause of death
among adults globally. This study examined the associations and clinical utilities of genetic …
among adults globally. This study examined the associations and clinical utilities of genetic …
[HTML][HTML] C-reactive protein and risk of cardiovascular events and mortality in patients with various cardiovascular disease locations
PM Burger, AD Pradhan, JAN Dorresteijn… - The American Journal of …, 2023 - Elsevier
Anti-inflammatory drugs reduce the risk of cardiovascular events in patients with coronary
artery disease (CAD), but less is known about the relation between inflammation and …
artery disease (CAD), but less is known about the relation between inflammation and …
[HTML][HTML] Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular disease
L Yang, Q Yue, F Fang, Y Zhang, P Liu, Z Zhang… - Cardiovascular …, 2023 - Springer
Background Randomized controlled trials confirm that risks of residual cholesterol and
residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid …
residual inflammation remains in patients with cardiovascular disease (CVD) even after lipid …
[HTML][HTML] Remnant cholesterol in atherosclerotic cardiovascular disease: a systematic review and meta-analysis
Background Accumulating evidence suggests a substantial contribution of remnant
cholesterol (RC) to residual risk for the development or relapse of atherosclerotic …
cholesterol (RC) to residual risk for the development or relapse of atherosclerotic …